This result is consistent with the notion that miR-27a is a putative MEG3 target24 and agrees with previous reports of upregulated miR-27a in CRC cell lines or serum and tumor tissues of CRC patients compared to controls58,59. The gene discussed is MEG3; the disease is neoplasm.